Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05997810 · ClinicalTrials.gov registry record

Parathyroid Tumor Clonal Status

A clinical trial of Primary Hyperparathyroidism and Parathyroid Tumor, sponsored by Washington University School of Medicine.

Recruiting
Registry status
839
Enrollment target
3
Study locations

NCT05997810 is a study of Primary Hyperparathyroidism and Parathyroid Tumor that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 839 participants, above the 632-participant average among 7 other Primary Hyperparathyroidism trials with a reported enrollment target (33% higher). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05997810, a study of Primary Hyperparathyroidism and Parathyroid Tumor, is actively recruiting participants, sponsored by Washington University School of Medicine.

RECRUITING
Registry status
839 participants
Enrollment target
3
Study locations

Study Summary

To define the frequency of monoclonal-X and polyclonal-X tumors in PHPT participants having parathyroidectomy (PTX) and to define the relationship between parathyroid tumor clonal status and multiple gland neoplasia (MGN), we will compare surgical and pathologic outcomes to tumor clonal status in a multicenter cohort of patients having bilateral neck exploration (BNE) and PTX (primary objectives).

Conditions Studied

Primary Hyperparathyroidism Parathyroid Tumor

Study Locations (3)

Alabama

  • University of Alabama-Birmingham - Birmingham

California

  • University of California-Department of Surgery - San Francisco

Pennsylvania

  • Hospital of the University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 839 participants
Start Date 2023-04-11
Est. Completion 2027-01

Sponsor

Washington University School of Medicine

1,502 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05997810

The ClinicalTrials.gov registry entry for NCT05997810 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 839 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 632-participant average among 7 other Primary Hyperparathyroidism trials with a reported enrollment target (33% higher). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Primary Hyperparathyroidism appearing as the primary indexed condition, and to 0 interventions.

NCT05997810 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Alabama, California, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05997810 about?

NCT05997810 is a clinical study titled "Parathyroid Tumor Clonal Status". To define the frequency of monoclonal-X and polyclonal-X tumors in PHPT participants having parathyroidectomy (PTX) and to define the relationship between parathyroid tumor clonal status and multiple gland neoplasia (MGN), we will compare surgical and pathologic outcomes to tumor clonal status in a ...

What is the current status of trial NCT05997810?

This trial is currently recruiting. The enrollment target is 839 participants. The study started on 2023-04-11. Estimated completion is 2027-01.

What conditions does trial NCT05997810 study?

This clinical trial studies the following conditions: Primary Hyperparathyroidism, Parathyroid Tumor.

Who is sponsoring clinical trial NCT05997810?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05997810 being conducted?

This trial has 3 study locations across Alabama, California, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Primary Hyperparathyroidism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Primary Hyperparathyroidism

All registered trials for this condition

Parathyroid Tumor

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.